0%
Under the aegis of N K Dhabhar Cancer Foundation and mentorship of Padmabhushan, Padma Shri Dr. Suresh H. Advani.
Next-Generation Therapies for Gastrointestinal Cancers - Series 3 is a prestigious oncology conference organized under the aegis of N K Dhabhar Cancer Foundation and mentorship of Padmabhushan, Padma Shri Dr. Suresh H. Advani (Chief Medical Oncologist & Hematologist, Sushrut Hospital and Research Center, Mumbai). Hosted at ITC Grand Central Parel, Mumbai, the event covers CINV targeted therapies, MSS Colorectal Cancers, FAPI PET theranostics in gastric cancer, Claudin 18.2 testing, VYLOY (Zolbetuximab), and Atezolizumab + Bevacizumab in Intermediate HCC.
The primary aim of Next-Generation Therapies for Gastrointestinal Cancers - Series 3 is to deliver updated, evidence-based scientific insights into gastrointestinal oncology, including advanced management strategies for colorectal, esophageal, gastric, and hepato-pancreato-biliary malignancies. The program seeks to foster multidisciplinary collaboration among clinical specialists, enhance diagnostic accuracy, and translate groundbreaking clinical trial data into daily clinical practice.
The program was conducted as a structured academic conference. The scientific agenda comprised keynote lectures by distinguished domain experts, case-based panel discussions on complex clinical scenarios, interactive Q&A sessions, and comprehensive reviews of landmark clinical trials in Gastrointestinal Oncology.
The conference successfully equipped participating healthcare professionals with practical strategies for optimizing clinical decision-making in Gastrointestinal Oncology. By establishing updated treatment algorithms and promoting collaborative care networks, the event reinforces commitment to improving patient survival rates and quality of life.